The active ingredient in the ASERVO EQUIHALER (ciclesonide inhalation spray) is ciclesonide, a glucocorticoid (steroid) that becomes activated in the lungs, which allows for the targeted delivery and activation of the medication. Aservo® EquiHaler® Video Display. Ingelheim, Germany, April 21, 2020 – Boehringer Ingelheim is proud to announce that its Aservo ® EquiHaler ® received a Red Dot Award for product design. In 2019, Boehringer Ingelheim achieved net sales of $21.3 billion (19 billion euros). The Aservo EquiHaler represents the culmination of over a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups. Description: ASERVO EQUIHALER (ciclesonide inhalation spray) is a non-pressurized metered dose inhaler and drug cartridge combination containing a solution of 30 mg/mL of the prodrug ciclesonide, which is enzymatically converted to the pharmacologically active metabolite desisobutyrylciclesonide (des-ciclesonide) following inhalation. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. From that date, Aservo ® EquiHaler ® will also be presented in the online exhibition on the Red Dot website. Horses with severe equine asthma struggle to breathe, even at rest. Looking at the cost of the aservo for anything other than short term use I think the flexineb would be more cost effective. Developed after a decade of collaboration between Boehringer Ingelheim’s human pharmaceutical and animal health businesses, the ASERVO EQUIHALER offers the promise of relief to thousands of horses that suffer from severe equine asthma, which affects 11 to 17 percent of horses. 2,3,4. Boehringer Ingelheim is the second largest animal health business in the world, with net sales of almost 4 billion euros in … Aservo EquiHaler, 343 micrograms per actuation, inhalation solution for horses is presented as an inhaler with a polyurethane nostril adapter. ASERVO EQUIHALER (ciclesonide inhalation spray) is a non-pressurized metered dose inhaler and drug cartridge combination containing a solution of 30 mg/mL of the prodrug ciclesonide, which is enzymatically converted to the pharmacologically active metabolite desisobutyrylciclesonide (des-ciclesonide) following inhalation. An industry first in equine medicine, the inhaler addresses an unmet need for horses with asthma. The ASERVO EQUIHALER marks an industry first in equine medicine, as until now, there has been no FDA-approved inhalant therapy for use in horses with severe equine asthma. Boehringer Ingelheim has announced the U.S. launch of the Aservo® EquiHaler® (ciclesonide inhalation spray), the first FDA-approved inhalant therapy for … Aservo TM EquiHaler TM is already responsibly manufactured; the eco-design is 100% propellant-free, and the body of the inhaler is made of up to 50% recycled materials.. Such particles are commonly found in hay and bedding. Boehringer Ingelheim Animal Health used the Respimat ™ inhaler, developed by the company’s human pharmaceutical business, as a basis to develop the unique Soft Mist ™ Technology of the ASERVO EQUIHALER, 5 which is designed specifically for use in horses. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. , Deaton, C.M. Aservo EquiHaler with a polyurethane nostril adapter contains a. pre-inserted cartridge. UK Tel: 01344 746960 (sales) … Boehringer Ingelheim is proud to announce that its Aservo® EquiHaler® received a Red Dot Award for product design. Aservo ® EquiHaler ® is an inhalant therapy licensed for use in horses with severe equine asthma. Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy Aservo® EquiHaler® is … ®. of Aservo ® EquiHaler ®, compared to a vehicle control product, while minimizing other possible influences on the horse’s clinical signs (including other interventions). The cartridge contains. Aservo EquiHaler 343 microgram For the alleviation of clinical symptoms of severe equine asthma characterized by coughing, nasal discharge, nasal flaring, increased breathing effort at rest, or abnormal lung sounds. 1, Weekes, J.S. UK Tel: 01344 746960 (sales) … Aservo™ EquiHaler™: A soaringachievement inequine asthma. Aservo EquiHaler is available by a veterinarian’s prescription only because professional expertise is required to properly diagnose severe equine asthma and monitor safe use of the product, including treatment of any adverse reactions. Aservo EquiHaler facilitates the treatment of equine asthma. BI launch inhalation solution for severe equine asthma 25 May 2021 Animal Health. Aservo® EquiHaler® is … Boehringer Ingelheim is proud to announce that its Aservo® EquiHaler® received a Red Dot Award for product design. Offer praise The Video display is easily converted into a stand for easy viewing by folding in the third panel. What Makes ASERVO EQUIHALER unique. The newly approved inhaler is designed specifically for use in horses. Aservo Equihaler can only be obtained with a prescription and should only be given if the veterinarian considers that the horse’s temperament is suitable for safe and effective use of Aservo Equihaler. Free Shipping over $59! Aservo ® EquiHaler ® is an inhalant therapy licensed for use in horses with severe equine asthma. Due to the integrated Soft Mist technology, the medication can be inhaled deeply into the lungs. Aservo ® EquiHaler ® 343 micrograms/actuation inhalation solution for horses contains ciclesonide. Boehringer Ingelheim Animal Health used the Respimat ™ inhaler, developed by the company’s human pharmaceutical business, as a basis to develop the unique Soft Mist ™ Technology of the ASERVO EQUIHALER, 5 which is designed specifically for use in horses. Boehringer Ingelheim Animal Health Business Unit. UK: POM-V IE: POM. The Red Dot Design Yearbook 2020/2021 comes out in July 2020. Aservo™ EquiHaler™, industry-first therapy for severe equine asthma, ... with net sales of 4.1 billion euros in 2020 and presence in more than 150 countries. The Respimat inhaler used in human respiratory disease is differentiated by the unique Soft Mist Technology, which was integrated into the new Aservo EquiHaler, allowing medication to be inhaled, deep into the lung. The Aservo EquiHaler represents the culmination of over a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups. 1 and Marlin, D.J. Aservo EquiHaler has been manufactured from up to 50 percent recycled materials – a real development for our market. All horses receive the same dose over 10 days. Awarded the Red Dot Award for outstanding design Aservo EquiHaler includes an ergonomic handle and dosing lever for ease of user handling, and a nostril adaptor that fits gently inside the nostril of the horse, allowing them to easily inhale the medicated mist. The Aservo® EquiHaler®(ciclesonide inhalation spray), an industry first in equine medicine, addresses an unmet need for horses with severe equine asthma ; Boehringer Ingelheim uses synergies between its human pharma and animal health research teams to set new standards of care ; Boehringer Ingelheim today announced the U.S. launch of the Aservo® EquiHaler® (ciclesonide … Boehringer Ingelheim's Aservo EquiHaler wins the Red Dot Award: Product Design 2020 Red Dot has become established internationally as one … The cartridge also contains an additional amount. sufficient inhalation solution for the entire treatment duration (140. treatment actuations). Aservo® EquiHaler® has been manufactured from up to 50% recycled materials – a real development for our market. An ergonomic handle with a dual-functional lever enables single-handed operation. Boehringer Ingelheim Animal Health Canada Inc. has been granted marketing authorization for Aservo™ EquiHaler™, an inhaled therapy for horses with severe asthma. Aservo EquiHaler is manufactured by Boehringer Ingelheim Animal Health USA, Inc. in Duluth, Georgia. In addition, Boehringer Ingelheim has partnered with us at TerraCycle® for the Aservo™ EquiHaler™ Recycling Program to make sure they are properly recycled and together contribute to a greener future. Boehringer Ingelheim has introduced Aservo EquiHaler to the UK and Irish markets, a ciclesonide inhalation solution designed to allow medication to be inhaled deep into the lungs of horses suffering severe asthma, reducing the lower airway inflammation associated with severe equine asthma and … The ASERVO EQUIHALER marks an industry first in equine medicine, as until now, there has been no FDA-approved inhalant therapy for use in horses with severe equine asthma. In this recording we review the treatment algorithm for severe equine asthma and the previously available treatment options. The Aservo™ EquiHaler™ is a prescription product, which means access to information about this drug is restricted by Canadian law to veterinarians and horse owners whose horses have already been prescribed Aservo™ EquiHaler… Boehringer Ingelheim used this video display to educate horse owners and staff on the proper administration of Aservo® Equihaler®, used in the treatment of equine asthma. Awarded the Red Dot Award for outstanding design Aservo® EquiHaler® includes an ergonomic handle and dosing lever for ease of user handling, and a nostril adaptor that fits gently inside the nostril of the horse, allowing them to easily inhale the medicated mist. UK: POM-V IE: POM. 8 Aservo® EquiHaler® Tips for the successful introduction of Aservo® EquiHaler® 1 Take time to reassure your horse Some horses may find the introduction of new objects alarming. covering priming and … Aservo™ EquiHaler™ (ciclesonide inhalation solution) leverages synergies between the company's human pharma and animal health divisions to set new standards of care. E. Esmae Well-Known Member. LABELLING continued PSD was determined with the MDI, actuator and spacer combined Together We Can Make a Difference in Your Practice - Family and Employee Owned Since 1961 Aservo EquiHaler 343 mcg/actuation and other products can be found at EntirelyPets Rx, the #1 source for fulfilling all of your pet needs. wins Red Dot for outstanding design quality. Boehringer Ingelheim is proud to announce that its Aservo EquiHaler received a Red Dot Award for product design. The Respimat inhaler used in human respiratory disease is differentiated by the unique Soft Mist Technology, which was integrated into the new Aservo EquiHaler, allowing medication to be inhaled, deep into the lung. Aservo ® EquiHaler ® 343 micrograms/actuation inhalation solution for horses contains ciclesonide. Phase 2 was designed to evaluate the safety of repeated use of Aservo ® EquiHaler ® if needed for continued control of the clinical signs associated with severe equine Severe equine asthma is an inflammatory disease of the lower airways caused by breathing in high concentrations of organic dust particles small enough to pass with air to the lower airways. The Aservo EquiHaler (ciclesonide inhalation spray), an industry first in equine medicine, addresses an unmet need for horses with severe ... and Biopharmaceutical Contract Manufacturing. Whoa there. A combination of a novel glucocorticoid (ciclesonide) and advanced inhalation technology (Soft Mist™ Inhaler) designed specifically for horses with severe equine asthma. Equine Healthcare APS, Denmark and 1Centre for Equine Studies, Animal Health Trust, Newmarket, UK. Aservo EquiHaler has not been evaluated for safety and effectiveness in other equids, such as donkeys or mules. - The Aservo® EquiHaler® (ciclesonide inhalation spray), an industry first in equine medicine, addresses an unmet need for horses with severe equine asthma DULUTH, Ga., Sept. 15, 2020 /PRNewswire/ -- Boehringer Ingelheim today announced the U.S. launch of the Aservo® EquiHaler® (ciclesonide inhalation spray), the first FDA-approved inhalant therapy for horses with severe equine … The Red Dot Award: Product Design is an international competition which originated more than 60 years ago, offering designers and manufacturers from all over the world a platform for evaluating quality for good design of their products. Without rushing, let them get used to the presence of the Aservo® EquiHaler® and show them it is nothing to be worried about. The Aservo ® EquiHaler ® is expected to be available for veterinarians in the EU in 2020. 29 August 2020 #8. EVALUATION OF A NEW SPACER DEVICE FOR DELIVERY OF DRUGS INTO THE EQUINE RESPIRATORY TRACT Funch-Nielsen, H., Roberts, C.A. EquiHaler.